Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to...
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.
Target Price
The average target price of NXS.AX is 0.27 and suggests 86% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell